Tatva Chintan Pharma Fact Sheet, Tatva Chintan Pharma Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Tatva Chintan Pharma Fact Sheet    (TATV)


EV Stocks: Make a Fortune from Automobile Sector's Colossal Disruption


Here is the latest financial fact sheet of Tatva Chintan Pharma. For more details, see the Tatva Chintan Pharma quarterly results and Tatva Chintan Pharma share price and chart.

TATVA CHINTAN PHARMA Price History

Price Rs 2,328.6
Mkt Cap Rs m 46,775
Vol '000 11.9
P/E X  
P/CF X 79.3
EPS (TTM) Rs 0.0
% ch % 0.3
No. of shares m 20.09
% ch week % 2.2
% ch 1-mth % 13.4
% ch 12-mth % -
52 week H/L Rs 2,486.3/2,000.8
(As on Oct 14, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

TATVA CHINTAN PHARMA Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
TATVA CHINTAN PHARMA EQUITY SHARE DATA
High RsNANANANANA 
Low RsNANANANANA 
Sales per share (Unadj.) Rs126.2168.5256.6327.4149.5 
Earnings per share (Unadj.) Rs21.516.225.647.026.0 
Diluted earnings per shareRs8.66.510.218.826.0 
Cash flow per share (Unadj.) Rs24.220.630.553.029.4 
Dividends per share (Unadj.) Rs00000 
Adj. dividends per shareRs0.000.000.000.000.00 
Avg Dividend yield %NMNMNMNMNM 
Book value per share (Unadj.) Rs61.677.499.1146.482.6 
Adj. book value per shareRs24.731.039.758.682.6 
Shares outstanding (eoy) m8.048.048.048.0420.09 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x00000 
Avg P/E ratio x00000 
P/CF ratio (eoy) x00000 
Price / Book Value ratio x00000 
Dividend payout %00000 
Avg Mkt Cap Rs m00000 
No. of employees `000NANANANANA 
Total wages/salary Rs m6495163205241 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
TATVA CHINTAN PHARMA INCOME DATA
Net Sales Rs m1,0151,3552,0632,6323,004 
Other income Rs m544851459 
Total revenues Rs m1,0691,4022,0682,6463,063 
Gross profit Rs m258215349553659 
Depreciation Rs m2236404867 
Interest Rs m1732394344 
Profit before tax Rs m273195274476607 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m10065699884 
Profit after tax Rs m173130205378523 
Gross profit margin %25.415.816.921.022.0 
Effective tax rate %36.733.425.020.613.9 
Net profit margin %17.19.610.014.417.4 
TATVA CHINTAN PHARMA BALANCE SHEET DATA
Current assets Rs m7588021,1441,3271,843 
Current liabilities Rs m5556277278771,180 
Net working cap to sales %20.013.020.217.122.1 
Current ratio x1.41.31.61.51.6 
Inventory Days Days293100 
Debtors Days Days102,925,52285,314,4327369110 
Net fixed assets Rs m4716707311,1621,306 
Share capital Rs m80808080201 
"Free" reserves Rs m4155427171,0971,459 
Net worth Rs m4956227971,1771,660 
Long term debt Rs m168202315387268 
Total assets Rs m1,2291,4721,8752,4893,148 
Interest coverage x16.77.27.912.214.6 
Debt to equity ratio x0.30.30.40.30.2 
Sales to assets ratio x0.80.91.11.11.0 
Return on assets %15.511.013.116.918.0 
Return on equity %35.020.925.832.131.5 
Return on capital %43.927.528.233.233.8 
Exports to sales %78.264.670.500 
Imports to sales %20.618.127.600 
Exports (fob) Rs m7938751,45500 
Imports (cif) Rs m20924657000 
Fx inflow Rs m7938751,45500 
Fx outflow Rs m22126857000 
Net fx Rs m57260788500 
TATVA CHINTAN PHARMA CASH FLOW
From Operations Rs m 243 0 74 253 243 
From Investments Rs m -246 0 -168 -402 -210 
From Financial Activity Rs m 148 0 174 100 -88 
Net Cashflow Rs m 145 0 80 -49 -55 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 86.9%
Institution 0.0%
Non-Institution 13.2%
Total 100.0%
Free Float 13.2%
Pledged promoter holdings 0.0%
 

Company Information

REGD OFF Plot No 502/17, Gidc Estate, Ankleshwar Gidc, Bharuch - 393002
E-MAIL chintan@tatvachintan.com WEB www.tatvachintan.com
TEL 026-46253593/75730 46951/75730 46952 FAX
SECTOR CHEMICALS & PESTICIDES GROUP Private sector
TR AGENT Link Intime India Pvt Ltd., C 101 247 Park, LBS Marg, Vikhroli (West)
YEAR OF INC: 1996 BSE CODE: 543321 FV (Rs): 10 DIV YIELD (%): -

More Chemicals & Pesticides Company Fact Sheets:   PRIVI SPECIALITY CHEMICALS  OLYMPIC OIL  INDO BORAX  SHARDA CROPCHEM  NEOGEN CHEMICALS  

Compare TATVA CHINTAN PHARMA With:   PRIVI SPECIALITY CHEMICALS  OLYMPIC OIL  INDO BORAX  SHARDA CROPCHEM  NEOGEN CHEMICALS  




Today's Market

Sensex Ends Above 61,000-Mark, Nifty Tops 18,300; Adani Ports, Wipro & Grasim Rally 5%(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended on a strong note.

Views on news

Tatva Chintan Makes Blockbuster Debut Doubling Investors Money (Views On News)

Jul 29, 2021

Tatva Chintan Pharma lists at 95% premium over issue price of Rs 1,083.

What Next for Devyani, Zomato, & Tatva Chintan Pharma After Stellar IPO Gains? (Views On News)

Aug 20, 2021

What's the outlook for Devyani, Zomato, and Tatva Chintan Pharma after robust listings?

Ami Organics Stock Makes Impressive Debut on Bourses. Lists at 49% Premium (Views On News)

Sep 14, 2021

Shares of Ami Organics makes a strong debut on the stock exchange. Did you bid for the IPO?

Chemplast Sanmar Makes Flat Debut as IPO Frenzy Fizzles Out (Views On News)

Aug 24, 2021

The grey market had indicated a flat listing for shares of Chemplast Sanmar ahead of its debut.

Understanding Aarti Industries' Demerger (Views On News)

Aug 20, 2021

Will the pharma unit's demerger unlock value for shareholders?

More Views on News

Most Popular

Is it Time to Switch from Tata Power to NTPC? (Profit Hunter)

Oct 11, 2021

Given the huge run up in Tata Power, does it make sense to switch to NTPC?

This Proxy EV Stock Just got a Power Crisis Boost (Profit Hunter)

Oct 8, 2021

After months of research, I've come across few stocks that excite me far more than the mainstream electric vehicle companies.

Rs 1 Lakh Invested in These Cryptos at the Start of 2021 Became Rs... (Views On News)

Oct 8, 2021

These cryptos would have multiplied investors' wealth by as much as 10,000% in just nine months.

Top 5 'Digital India' Stocks (Views On News)

Oct 6, 2021

These companies are leading the Government's US$1 tn 'Digital India' initiative.

5 Exciting 'Unlisted' Companies and How to Play Them (Views On News)

Oct 7, 2021

Here's how you can invest in some of the most exciting start-ups of the decade.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK TATVA CHINTAN PHARMA

  • Track your investment in TATVA CHINTAN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TATVA CHINTAN PHARMA

TATVA CHINTAN PHARMA - KELTECH EN. COMPARISON

COMPARE TATVA CHINTAN PHARMA WITH

MARKET STATS